 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 01/10/2022 |
$0.61 |
$0.85 |
$0.61 |
$0.73 |
38.44M | | 01/11/2022 |
$0.71 |
$0.73 |
$0.67 |
$0.68 |
3.89M | | 01/12/2022 |
$0.68 |
$0.71 |
$0.65 |
$0.67 |
2.41M | | 01/13/2022 |
$0.67 |
$0.68 |
$0.61 |
$0.63 |
1.61M | | 01/14/2022 |
$0.63 |
$0.66 |
$0.60 |
$0.61 |
1.82M |
|
|
| Adamis Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including opioid overdose, respiratory and inflammatory disease. Co.'s products and product candidates include: Symjepi (epinephrine) Injection 0.3mg for use in the treatment of acute allergic reactions, including anaphylaxis; SYMJEPI (epinephrine) Injection 0.15mg for use in the treatment of anaphylaxis for patients weighing 33 to 65 pounds; a naloxone injection product candidate ZIMHI for the treatment of opioid overdose; Tempol, an investigational drug; and a Beclomethasone metered dose inhaler product candidate (APC-1000) for the treatment of asthma. | |
|
Adamis Pharmaceuticals (ADMP) has the following price history information. Looking back at ADMP historical stock prices for the last five trading days, on January 10, 2022, ADMP opened at $0.61, traded as high as $0.85 and as low as $0.61, and closed at $0.73. Trading volume was a total of 38.44M shares. On January 11, 2022, ADMP opened at $0.71, traded as high as $0.73 and as low as $0.67, and closed at $0.68. Trading volume was a total of 3.89M shares. On January 12, 2022, ADMP opened at $0.68, traded as high as $0.71 and as low as $0.65, and closed at $0.67. Trading volume was a total of 2.41M shares. On January 13, 2022, ADMP opened at $0.67, traded as high as $0.68 and as low as $0.61, and closed at $0.63. Trading volume was a total of 1.61M shares. On January 14, 2022, ADMP opened at $0.63, traded as high as $0.66 and as low as $0.60, and closed at $0.61. Trading volume was a total of 1.82M shares.
ADMP Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Adamis Pharmaceuticals shares, starting with a $10,000 purchase of ADMP, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/19/2012 |
|
| End date: |
01/14/2022 |
|
| Start price/share: |
$2.89 |
|
| End price/share: |
$0.61 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-78.89% |
|
| Average Annual Total Return: |
-14.41% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$2,111.55 |
|
| Years: |
9.99 |
|
|
|
| Date |
Close |
| 01/10/2022 | $0.73 | | 01/11/2022 | $0.68 | | 01/12/2022 | $0.67 | | 01/13/2022 | $0.63 | | 01/14/2022 | $0.61 |
|
|
Free ADMP Email Alerts:
